RedHill Biopharma(RDHL) - 2024 Q4 - Annual Report

For the month of April 2025 Commission File No.:001-35773 REDHILL BIOPHARMA LTD. (Translation of registrant's name into English) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F. 21 Ha'arba'a Street, Tel Aviv, 6473921, Israel Form 20-F ☒ Form 40-F ☐ Attached ...